Clinical Trial Management Services Market Trends Analysis Report 2024: A $53.85 Billion Industry by 2030, Driven by Demand for Novel Pharmaceuticals and Rise in R&D Expenditure - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Management Services Market Size, Share & Trends Analysis Report By Services, By Indication, By End Use, By Region, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global clinical trial management services market size is anticipated to reach USD 53.85 billion by 2030 and is expected to expand at a CAGR of 8.26% from 2025 to 2030.

The increasing trend of outsourcing clinical trial activities, the rise in research and development of advanced therapies, and the globalization of clinical trials are a few key factors driving the growth of the market.

The number of clinical trials has significantly increased in the past two decades. This is due to the rising need for novel pharmaceutical products with improved efficacy as well as the increasing penetration of cutting-edge medical technologies. According to Clinical trials.gov, the total number of clinical trials accounted for 325,773 in 2020, whereas, as of April 2022, the number of clinical trials this year totaled more than 410,903.

Clinical trial management services such as clinical monitoring, data management, site monitoring, and medical writing service are cost-effective and time-saving. These also harmonize clinical data across sites and failure rates. Furthermore, the integration of digital technologies, including cloud computing, Artificial Intelligence (AI), big data prescriptive, and predictive analytics, the Internet of Medical Things, and mobile technology remain major developments on the horizon. These technologies have shown great promise in improving productivity while accelerating the pace of clinical trials.

The COVID-19 pandemic significantly impacted the market. It created an unexpected urgency for alternative solutions to clinical trial execution, limiting on-site monitoring visits. It prompted researchers to use remote clinical trial monitoring services and platforms to reduce the spread of the COVID-19 infection as well as to simultaneously function in clinical research. For instance, according to the Florence survey in 2020, more than 60% of clinical study sites and clinical trial sponsors stated more than 50% acceptance of remote site monitoring solutions for clinical research.

Clinical Trial Management Services Market Report Highlights

• The clinical trial monitoring segment dominated the clinical trial management services industry in 2024.
• The oncology segment dominated the clinical trial management services industry in 2024. The rise in oncology R&D investments, the increasing cancer incidences, and the growing demand for personalized medications, coupled with a surge in innovative developments in the field of oncology, are the key factors driving the growth.
• The pharmaceuticals segment dominated the clinical trial management services industry in 2024. This can be largely attributed to the rise in R&D investments and the development of new drugs over the past two decades.
• North America dominated the clinical trial management services market. The demand for new therapies and drugs has led to a surge in clinical trials across the region.

Competitive Landscape

• CTI Clinical Trial & Consulting
• Charles River Laboratories
• Medpace Holdings, Inc.
• Wuxi Apptec
• SGS Societe Generale de Surveillance SA
• Laboratory Corporation of America Holdings
• IQVIA, Inc.
• Syneous Health
• Atlantic Research Group
• ICON Plc

Key Attributes:

Report Attribute	Details
No. of Pages	145
Forecast Period	2024 - 2030
Estimated Market Value (USD) in 2024	$33.46 billion
Forecasted Market Value (USD) by 2030	$53.85 billion
Compound Annual Growth Rate	8.2%
Regions Covered	Global

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

Chapter 3. Clinical Trial Management Services Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Ancillary Market Outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.1.1. Increasing technological advancement in the clinical trial monitoring services

3.2.1.2. Rise in R&D expenditure by pharmaceutical and biopharmaceutical companies

3.2.1.3. Growth in the number of outsourced projects related to clinical trial management services

3.2.2. Market Restraint Analysis

3.2.2.1. High cost associated with clinical trial management services

3.2.2.2. Stringent regulatory policies for clinical trial management services

3.3. Clinical Trial Management Services Market: Analysis Tools

3.3.1. Porter's Five Forces Analysis

3.3.2. PESTEL Analysis

3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Management Services Market: Services Estimates & Trend Analysis

4.1. Segment Dashboard

4.2. Global Clinical Trial Management Services Market, Services Movement Analysis

4.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by Services, 2018 to 2030 (USD Million)

4.4. Clinical Trial Monitoring

4.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

4.5. Regulatory Submissions

4.6. Clinical Trial Data Management

4.7. Medical Writing

4.8. Site Management

4.9. Project Management

4.10. Others

Chapter 5. Clinical Trial Management Services Market: Indication Estimates & Trend Analysis

5.1. Segment Dashboard

5.2. Global Clinical Trial Management Services Market, Indication Movement Analysis

5.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)

5.4. Autoimmune/Inflammation

5.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

5.5. Pain Management

5.6. Oncology

5.7. CNS Conditions

5.8. Diabetes

5.9. Obesity

5.10. Cardiovascular

5.11. Others

Chapter 6. Clinical Trial Management Services Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard

6.2. Global Clinical Trial Management Services Market, End Use Movement Analysis

6.3. Global Clinical Trial Management Services Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)

6.4. Pharmaceuticals

6.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

6.5. Biopharmaceuticals

6.6. Medical Devices

Chapter 7. Clinical Trial Management Services Market: Regional Estimates & Trend Analysis

7.1. Regional Market Dashboard

7.2. Global Regional Market Snapshot

7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030

Chapter 8. Competitive Landscape

8.1. Market Participant Categorization

8.1.1. Market Leaders

8.1.2. Emerging Players

8.2. Company Market Position Analysis

8.3. Company Profiles

8.3.1. Company Overview

8.3.2. Financial Performance

8.3.3. Service Benchmarking

8.3.4. Strategic Initiatives

For more information about this report visit https://www.researchandmarkets.com/r/um1leb

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.